183 related articles for article (PubMed ID: 9661134)
21. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
22. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
23. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.
Bunkenburg B; Schnell C; Baum HP; Cumin F; Wood JM
Hypertension; 1991 Sep; 18(3):278-88. PubMed ID: 1889842
[TBL] [Abstract][Full Text] [Related]
24. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
[TBL] [Abstract][Full Text] [Related]
25. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
26. Role of endogenous angiotensin II on sympathetic reflexes in conscious rabbits.
Bendle RD; Malpas SC; Head GA
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1816-25. PubMed ID: 9227595
[TBL] [Abstract][Full Text] [Related]
27. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Cazes M; Provost D; Versigny A; Cloarec A
Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of angiotensin II and the influence of angiotensin receptor antagonists in pithed rabbits.
Zhang J; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1995 May; 25(5):724-31. PubMed ID: 7630151
[TBL] [Abstract][Full Text] [Related]
29. Characterization of contractile response to angiotensin in epididymal rat vas deferens.
Sum CS; Cheung WT
Pharmacology; 1995 Aug; 51(2):105-11. PubMed ID: 8584570
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
Cox SL; Ben A; Story DF; Ziogas J
Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
32. Positive inotropic action of angiotensin II in the pithed rat.
Zhang J; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):658-63. PubMed ID: 8103195
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat.
Dendorfer A; Raasch W; Tempel K; Dominiak P
J Hypertens; 2002 Jun; 20(6):1151-6. PubMed ID: 12023685
[TBL] [Abstract][Full Text] [Related]
34. Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.
Nap A; Balt JC; Pfaffendorf M; Van Zwieten PA
J Hypertens; 2002 Sep; 20(9):1821-8. PubMed ID: 12195125
[TBL] [Abstract][Full Text] [Related]
35. Sodium intake, angiotensin II receptor blockade, and baroreflex function in conscious rats.
Xu L; Brooks VL
Hypertension; 1997 Jan; 29(1 Pt 2):450-7. PubMed ID: 9039141
[TBL] [Abstract][Full Text] [Related]
36. A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.
Rechtman M; Majewski H
Br J Pharmacol; 1993 Sep; 110(1):289-96. PubMed ID: 8220890
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
Nagura J; Yasuda S; Fujishima K; Yamamoto M; Hui C; Kawano K; Katano K; Ogino H; Hachisu M; Konno F
Eur J Pharmacol; 1995 Feb; 274(1-3):201-11. PubMed ID: 7768273
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
39. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
Brännström K; Morsing P; Arendshorst WJ
Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
[TBL] [Abstract][Full Text] [Related]
40. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
Richer C; Domergue V; Vincent MP; Giudicelli JF
Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
